Breaking News

Eurofins To Combine Businesses

April 2, 2014

Bio-analytical testing and genomic services becomes Eurofins Genomics

Eurofins Scientific is combining its bio-analytical testing and genomic services to provide a complete suite of services. Eurofins MWG Operon, a provider of genomic services, and Eurofins Medigenomix, the Group’s competence center for applied solutions in DNA & RNA analysis, will be brought together under the brand name Eurofins Genomics.
 
Eurofins Genomics will operate R&D and production sites in the U.S. in Huntsville, AL and Louisville, KY, as well as in Ebersberg, Germany, Bangalore, India, and Tokyo, Japan.
 
Bruno Poddevin, senior vice president of Eurofins Genomics, said, “After years of continuous growth within the Eurofins Scientific network, I am extremely happy to align our traditional brands, “MWG”, “Operon” and “Medigenomix”, under a single brand which is synonymous with our commitment to be first-in-class provider of genomic services. This underlines our goal to strengthen our global position as the leading supplier of applied genomics solutions in the future.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.